PT1140168E - Vacinacoes contra o cancro - Google Patents

Vacinacoes contra o cancro

Info

Publication number
PT1140168E
PT1140168E PT00906191T PT00906191T PT1140168E PT 1140168 E PT1140168 E PT 1140168E PT 00906191 T PT00906191 T PT 00906191T PT 00906191 T PT00906191 T PT 00906191T PT 1140168 E PT1140168 E PT 1140168E
Authority
PT
Portugal
Prior art keywords
against cancer
vaccinations against
vaccinations
prophylactically
medicament
Prior art date
Application number
PT00906191T
Other languages
English (en)
Inventor
Hans Loibner
Helmut Eckert
Original Assignee
Igeneon Krebs Immuntherapie F
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Igeneon Krebs Immuntherapie F filed Critical Igeneon Krebs Immuntherapie F
Publication of PT1140168E publication Critical patent/PT1140168E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT00906191T 1999-01-13 2000-01-12 Vacinacoes contra o cancro PT1140168E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH5199 1999-01-13

Publications (1)

Publication Number Publication Date
PT1140168E true PT1140168E (pt) 2002-11-29

Family

ID=4178206

Family Applications (2)

Application Number Title Priority Date Filing Date
PT00906191T PT1140168E (pt) 1999-01-13 2000-01-12 Vacinacoes contra o cancro
PT02005394T PT1230932E (pt) 1999-01-13 2000-01-12 Uso de anticorpos para vacinacao contra o cancro

Family Applications After (1)

Application Number Title Priority Date Filing Date
PT02005394T PT1230932E (pt) 1999-01-13 2000-01-12 Uso de anticorpos para vacinacao contra o cancro

Country Status (28)

Country Link
US (3) US7691372B2 (pt)
EP (2) EP1140168B1 (pt)
JP (1) JP4774551B2 (pt)
KR (1) KR100771752B1 (pt)
CN (1) CN1188169C (pt)
AT (2) ATE286745T1 (pt)
AU (1) AU768515B2 (pt)
CA (1) CA2360382C (pt)
CZ (1) CZ302801B6 (pt)
DE (2) DE50000243D1 (pt)
DK (2) DK1230932T3 (pt)
EE (1) EE05474B1 (pt)
ES (2) ES2236375T3 (pt)
HK (1) HK1044487B (pt)
HR (1) HRP20010526A2 (pt)
HU (1) HU226150B1 (pt)
ID (1) ID30223A (pt)
IL (2) IL144265A0 (pt)
IS (1) IS5998A (pt)
MX (1) MXPA01007148A (pt)
NO (1) NO329917B1 (pt)
NZ (1) NZ512722A (pt)
PL (1) PL201533B1 (pt)
PT (2) PT1140168E (pt)
SI (2) SI1230932T1 (pt)
SK (1) SK286627B6 (pt)
TR (1) TR200102034T2 (pt)
WO (1) WO2000041722A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1140168E (pt) * 1999-01-13 2002-11-29 Igeneon Krebs Immuntherapie F Vacinacoes contra o cancro
AT410172B (de) * 2000-03-21 2003-02-25 Igeneon Gmbh Verfahren zur herstellung einer vakzineformulierung
AT502293B1 (de) * 2002-05-15 2008-03-15 Igeneon Krebs Immuntherapie Immunogener, monoklonaler antikörper
AT500647A1 (de) * 2002-05-21 2006-02-15 Igeneon Krebs Immuntherapie Verwendung eines impfstoffes
AT500650B1 (de) 2003-04-17 2009-11-15 Altropus Gmbh Immunogener rekombinanter antikörper
AT500651B9 (de) * 2003-05-27 2010-04-15 Altropus Gmbh Aktiv immunisierender antikörper
CA2573505C (en) 2004-07-14 2013-06-25 Igeneon Krebs-Immuntherapie Forschungs-Und Entwicklungs-Ag N-glycosylated antibody
DE602004029455D1 (de) * 2004-07-20 2010-11-18 Altropus Gmbh Verwendung von Antikörpern in einer sehr geringen Dosis zur Impfung gegen Krebs
KR101205064B1 (ko) * 2005-04-26 2012-11-27 에자이 알앤드디 매니지먼트 가부시키가이샤 암 면역요법을 위한 조성물과 방법
EP1762575A1 (en) * 2005-09-12 2007-03-14 Ganymed Pharmaceuticals AG Identification of tumor-associated antigens for diagnosis and therapy
AT504231A1 (de) 2006-10-03 2008-04-15 Hans Dr Loibner Prädiktive parameter
EP2898889B1 (en) 2007-12-07 2017-03-22 N.V. Nutricia Bifidobacterium for dust mite allergy
JP5764071B2 (ja) 2009-02-24 2015-08-12 エスバテック − ア ノバルティスカンパニー エルエルシー 細胞表面抗原のイムノバインダーを同定するための方法
US8887373B2 (en) 2012-02-24 2014-11-18 Covidien Lp Vessel sealing instrument with reduced thermal spread and method of manufacture therefor
US20140276968A1 (en) * 2013-03-14 2014-09-18 Ethicon, Inc. Applicator systems for surgical fasteners
WO2015013668A1 (en) * 2013-07-26 2015-01-29 Ke Zhang Anti-immunoglobulin e antibodies and methods of use thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341281C (en) * 1986-07-09 2001-08-07 Hubert J.P. Schoemaker Immunotherapy of tumor with monoclonal antibody against the 17-1a antigen
US5270202A (en) * 1989-11-03 1993-12-14 Syamal Raychaudhuri Anti-idiotypic antibodies to human melanoma-associated proteoglycan antigen
US5965132A (en) * 1992-03-05 1999-10-12 Board Of Regents, The University Of Texas System Methods and compositions for targeting the vasculature of solid tumors
US5798100A (en) * 1994-07-06 1998-08-25 Immunomedics, Inc. Multi-stage cascade boosting vaccine
WO1997005597A1 (en) * 1995-07-31 1997-02-13 Litton Systems Canada Limited Flat panel pixel array incorporating photoconductive switches
EP0857176A1 (en) * 1995-10-25 1998-08-12 Centocor B.V. HUMAN EPITHELIAL ANTIGEN Ep-CAM DERIVED PEPTIDES AND THEIR USE
US6235280B1 (en) * 1996-04-12 2001-05-22 Malaya Chatterjee Methods of delaying development of CEA-associated tumors using anti-idiotype antibody 3H1
IL121041A0 (en) * 1997-06-09 1997-11-20 Yeda Res & Dev Immunogenic compositions for induction of anti-tumor immunity
US6274143B1 (en) * 1997-06-13 2001-08-14 Malaya Chatterjee Methods of delaying development of HMFG-associated tumors using anti-idiotype antibody 11D10
EP1085905B1 (en) * 1998-06-15 2010-09-08 Quest Pharmatech Inc. Immunotherapeutic composition and method for the treatment of prostate cancer
PT1140168E (pt) * 1999-01-13 2002-11-29 Igeneon Krebs Immuntherapie F Vacinacoes contra o cancro
AU2001261371A1 (en) * 2000-05-16 2001-11-26 New York University Anti-idiotypic antibody against fimh adhesin of uropathogenic type i-fimbriated escherichia coli, compositions containing same and method for using same

Also Published As

Publication number Publication date
ATE219687T1 (de) 2002-07-15
EP1230932A2 (de) 2002-08-14
PL364747A1 (en) 2004-12-13
ES2177509T3 (es) 2002-12-16
CZ302801B6 (cs) 2011-11-16
AU768515B2 (en) 2003-12-18
KR100771752B1 (ko) 2007-10-30
CN1344167A (zh) 2002-04-10
JP4774551B2 (ja) 2011-09-14
SI1140168T1 (en) 2002-10-31
KR20010101446A (ko) 2001-11-14
ATE286745T1 (de) 2005-01-15
NO20013093L (no) 2001-09-10
EE200100366A (et) 2002-10-15
US8444974B2 (en) 2013-05-21
US20070224202A1 (en) 2007-09-27
EP1230932A3 (de) 2003-11-26
HU226150B1 (en) 2008-05-28
SI1230932T1 (en) 2005-06-30
DK1140168T3 (da) 2002-09-30
ID30223A (id) 2001-11-15
EE05474B1 (et) 2011-10-17
MXPA01007148A (es) 2002-03-27
HK1044487A1 (en) 2002-10-25
DK1230932T3 (da) 2005-04-25
EP1140168A1 (de) 2001-10-10
NZ512722A (en) 2003-07-25
SK286627B6 (sk) 2009-02-05
PT1230932E (pt) 2005-04-29
DE50000243D1 (de) 2002-08-01
EP1230932B1 (de) 2005-01-12
US7691372B2 (en) 2010-04-06
IL144265A0 (en) 2002-05-23
WO2000041722A1 (de) 2000-07-20
US20100233178A1 (en) 2010-09-16
NO329917B1 (no) 2011-01-24
DE50009240D1 (de) 2005-02-17
SK9642001A3 (en) 2002-03-05
IL144265A (en) 2006-08-20
CN1188169C (zh) 2005-02-09
CA2360382C (en) 2011-05-24
AU2796400A (en) 2000-08-01
TR200102034T2 (tr) 2001-11-21
HK1044487B (zh) 2005-09-16
CZ20012581A3 (cs) 2002-01-16
IS5998A (is) 2001-07-10
US20120003232A1 (en) 2012-01-05
JP2002534481A (ja) 2002-10-15
NO20013093D0 (no) 2001-06-21
CA2360382A1 (en) 2000-07-20
HRP20010526A2 (en) 2002-08-31
EP1140168B1 (de) 2002-06-26
PL201533B1 (pl) 2009-04-30
ES2236375T3 (es) 2005-07-16
HUP0200527A2 (en) 2002-06-29

Similar Documents

Publication Publication Date Title
PT1140168E (pt) Vacinacoes contra o cancro
TR200001253T2 (tr) Tümöre özel antijenler
CY1112753T1 (el) Θεραπευτικη αγωγη καρκινων του ανθρωπινου σωματος με τη χρηση toy ετ743
CY1110322T1 (el) Αναστολεις της her3 δραστικοτητας
BR0210628A (pt) Liberação intradérmica de vacinas e agentes terapêuticos genéticos via microcânula
ATE288502T1 (de) Gezieltes antikörper-verfahren
DE50002293D1 (de) Verwendung von csf-1-inhibitoren
BR0108471A (pt) Objeto pré-formado para liberar um agente ativo a um paciente, e, processos de formação de um objeto pré-formado para liberar um agente e de liberação de um agente ativo a um paciente
CY1110783T1 (el) Μονοκλωνικα αντισωματα κατα αυξητικου παραγοντα ηπατοκυτταρων
CY1108377T1 (el) Χρηση ενωσεων 1-φαινυλο-3-διμεθυλαμινο-προπανιου για τη θεραπεια της ακρατειας ουρων
NO20032027D0 (no) Effektive antitumorbehandlinger
ATE407147T1 (de) Fab-fragmente humaner monoklonaler antikörper mit neutralisierender aktivität gegen das hcv e2 glycoprotein
DK1699480T3 (da) Allogent terapeutisk tumormiddel
IS2259B (is) Aðferð til meðferðar á netjuhersli með notkun mótlyfs við integríninu alfa-4 undireiningunni
BR0315604A (pt) Composição de liberação controlada para administração oral de drogas
CY1105317T1 (el) Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων
CY1105142T1 (el) Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων
PT1229936E (pt) Uso de anticorpos anti-idiotipicos como vacina contra o cancro
DK1343896T3 (da) Lille syreoplöseligt sporeprotein og anvendelser deraf
WO2004106379A8 (en) Immunotherapy of rectal cancer
AP2003002852A0 (en) Natural antibodies active against HIV virus
UA40393A (uk) Спосіб лікування хронічного обструктивного бронхіту